Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission.

Satish, Tejus; Khan, Shaheer; Levin, Matt; Carvajal, Richard; Yoon, Angela J

Satish, Tejus; Khan, Shaheer; Levin, Matt; Carvajal, Richard; Yoon, Angela J.

Affiliation

Satish T; Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Khan S; Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, New York, USA.
Levin M; Cell IDx, San Diego, California, USA.
Carvajal R; Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, New York, USA.
Yoon AJ; Division of Oral and Maxillofacial Pathology, Columbia University Irving Medical Center, New York, New York, USA ajk55@cumc.columbia.edu.

J Immunother Cancer ; 9(10)2021 10.

Article in En | MEDLINE | ID: mdl-34716205

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Imiquimod/toxicity; Melanoma/complications; Melanoma/drug therapy; Mouth/pathology; Administration, Topical; Antibodies, Monoclonal, Humanized/pharmacology; Antineoplastic Combined Chemotherapy Protocols/pharmacology; Female; Humans; Imiquimod/pharmacology; Melanoma/pathology; Middle Aged; Treatment Outcome

Key words

case reports; immunomodulation; immunotherapy; melanoma

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Antibodies, Monoclonal, Humanized / Imiquimod / Melanoma / Mouth Limits: Female / Humans / Middle aged Language: En Journal: J Immunother Cancer Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google